ReviewPathogens (Basel, Switzerland)2022
Vector Competence of Mediterranean Mosquitoes for Rift Valley Fever Virus: A Meta-Analysis.
Review in Pathogens (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 24 citations in OpenAlex.
- Rift Valley Fever at Europe's Risk Frontier: Climate, Vectors, and One Health Preparedness.Veterinary sciences · 2026Review
- Evaluating the Role ofViruses · 2026Review
- Article
- Progress in research on mosquito-borne viruses: Understanding infection, transmission, and control.Infectious diseases & immunity · 2026Review
- Emerging and re-emerging vector-borne and other zoonotic RNA viruses: pathogenesis, climate-driven dynamics, and strategies for global control.Frontiers in microbiology · 2026Review
- The mosquitoes (Diptera: Culicidae) of Tunisia: updated checklist and new distribution data.Parasite (Paris, France) · 2026Article
- Seasonal variation in mosquito abundance and environmental predictors in semi-pastoral southern Kenya: implications for endemic Rift Valley fever.Parasites & vectors · 2025Article
- First characterization of mosquito vector abundance and diversity on commercial swine farms in the United States.Scientific reports · 2025Article
- RNA sequencing analysis of viromes ofProceedings of the National Academy of Sciences of the United States of America · 2025Article
- Genetic diversity and population structure of Aedes caspius in Iran.Scientific reports · 2025Article
- The Temperature-Associated Effects of Rift Valley Fever Virus Infections in Mosquitoes and Climate-Driven Epidemics: A Review.Viruses · 2025Review
- Distribution and abundance of Aedes caspius (Pallas, 1771) and Aedes vexans (Meigen, 1830) in the Po Plain (northern Italy).Parasites & vectors · 2024Article
- Tissue distribution and transmission of Rift Valley fever phlebovirus in EuropeanThe Journal of general virology · 2024Article
- Quantifying Rift Valley fever virus transmission efficiency in a lamb-mosquito-lamb model.Frontiers in cellular and infection microbiology · 2023Article
- Intranasal Exposure to Rift Valley Fever Virus Live-Attenuated Strains Leads to High Mortality Rate in Immunocompetent Mice.Viruses · 2022Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rift Valley fever (RVF) is a zoonotic disease caused by a virus mainly transmitted by
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.